OFIX (OFIX) revenue breakdown
By segment, Global Spine is the largest at 84% of fiscal 2025 revenue, growing 10% a year over 8 years.
By region, U.S. is the largest at 83% of fiscal 2025 revenue, growing 9% a year over 9 years.
Revenue by segment
Fiscal years, as OFIX reports them in its 10-K filings; fiscal 2025 total $822M.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Spine | — | $331M | $347M | $357M | $322M | $359M | $353M | $631M | $675M | $688M | 84% |
| Global Limb Reconstruction | $103M | $103M | $106M | $103M | $85M | $106M | $108M | $115M | $124M | $135M | 16% |
| Bone Growth Therapies | $177M | — | — | — | — | — | — | — | — | — | — |
| Spinal Implants | $73M | — | — | — | — | — | — | — | — | — | — |
| Biologics | $58M | — | — | — | — | — | — | — | — | — | — |
Revenue by region
Fiscal years, as OFIX reports them in its 10-K filings; fiscal 2025 total $822M.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. | $317M | $345M | $355M | $362M | $327M | $362M | $359M | $621M | $673M | $684M | 83% |
| Others | $48M | $45M | $51M | $39M | $31M | $42M | $45M | $66M | $66M | $77M | 9% |
| Italy | $17M | $17M | $19M | $20M | $19M | $20M | $19M | $20M | $21M | $22M | 3% |
| United Kingdom | $10M | $9M | $9M | $10M | $7M | $11M | $10M | $11M | $11M | $13M | 2% |
| France | — | — | — | $9M | $8M | $10M | $10M | $11M | $13M | $12M | 1% |
| Germany | $6M | $7M | $12M | $13M | $12M | $14M | $12M | $11M | $9M | $9M | 1% |
| Brazil | $11M | $10M | $7M | $8M | $2M | $5M | $6M | $6M | $6M | $5M | 1% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for OFIX.
Open OFIX in InvestinglyQuestions
Where does OFIX make its money?
In fiscal 2025, by segment: Global Spine $688M, Global Limb Reconstruction $135M.
From OFIX's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.